Home
Caligan Partners reported a 4.9% stake in Avalo Therapeutics AVTX · 881,533 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.9%
- Last report
- 6.3% · filed 25/11/14
- Shares held
- 881,533 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Caligan Partners
- Event date
- 25/12/31
- Filed
- 26/02/17
4.9% stake · below 5%
- Stake
- 4.9%
- Last report
- 6.3%
- Since last report
- −1.4pp
Avalo Therapeutics trades, last 26 weeks
What else happened in Avalo Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Caligan Partners's other 5% stake reports
- Caligan Partners
5% stakeSAB Biotherapeutics
5% stakeSAB Biotherapeutics
SABS
8.8% stake
7,967,207 sh
8.8% stake
Filed 08/14
- Caligan Partners
5% stakeAvalo Therapeutics
5% stakeAvalo Therapeutics
AVTX
5.9% stake
3,163,866 sh
5.9% stake
Filed 08/14
- Caligan Partners
5% stakeOpus Genetics
5% stakeOpus Genetics
IRD
7.3% stake
6,077,084 sh
7.3% stake
Filed 08/14
- Caligan Partners
5% stakeFaeth Therapeutics
5% stakeFaeth Therapeutics
FTH
2.4% stake
629,467 sh
2.4% stake
Filed 08/14
- Caligan Partners
5% stakeCellectar Biosciences
5% stakeCellectar Biosciences
CLRB
5.9% stake
469,998 sh
5.9% stake
Filed 08/14
